Author | Donald H. Batts, MD

Articles

Linezolid-A New Option for Treating Gram-Positive Infections

August 01, 2000

ByDonald H. Batts, MD

The increase in serious gram-positive infections has increased the need for treatment of gram-positive infections in patients with hematologic malignancies. Common gram-positive pathogens exhibit a variety of resistance

Current Issues in the Treatment of Resistant Bloodstream Infections

August 01, 2000

ByJames C. Wade, MD|Donald H. Batts, MD|John N. Greene, MD|David C. Linch, MD|Georg Maschmeyer, MD, PhD|Carole B. Miller, MD|Gary A. Noskin, MD|Patricia Ribaud, MD|Kenneth V. I. Rolston, MD|Kent A. Sepkowitz, MD|James A. Talcott, MD

Bloodstream infections cause significant morbidity and mortality for patients with hematologic malignancy. Antimicrobial drugs are the most reliable currently available treatment for infection, but several issues must be